- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02885350
Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour
May 27, 2021 updated by: Jouni Ahonen, Helsinki University Central Hospital
In this study the analgesic effect of two different opioids (fentanyl and sufentanil) will be compared when given either intrathecally or epidurally in primiparous parturients during early phase of the labour.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Uusimaa
-
Helsinki, Uusimaa, Finland, FI-00610
- Maternity Hospital, Helsinki University Central Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Primiparous parturients
- In early phase of labour (cervical dilatation at or under 5 cm)
- No prior opioids by any route of administration within past 120 min
- Pain at or over 80 mm on 0-100 mm visual analog scale during contraction
Exclusion Criteria:
- Allergy for any of the medications used
- Contraindications for epidural/spinal analgesia
- BMI at the time of delivery under 20 or over 35 kg/m2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Spinal fentanyl
20 micrograms of intrathecally administered fentanyl in single dose.
Total volume of intrathecal injection 2 ml.
|
Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique
|
|
Experimental: Epidural fentanyl
100 micrograms of epidurally administered fentanyl in a single dose.
Total volume of epidural injection 7 ml.
|
Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.
Other Names:
|
|
Active Comparator: Spinal sufentanil
5 micrograms of intrathecally administered sufentanil in a single dose.
Total volume of intrathecal injection 2 ml.
|
Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique
|
|
Experimental: Epidural sufentanil
20 micrograms of epidurally administered sufentanil in a single dose.
Total volume of epidural injection 7 ml.
|
Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Maximum Pain During Contraction at 20 Minutes After the Study Drug Delivery
Time Frame: 20 minutes
|
All parturients are to have a pain visual analog scale (VAS - on a 0-100 mm scale) at 80mm or higher before the initial study drug delivery.
On this scale 0 mm presents a totally pain free condition while 100 mm presents the worst imaginable pain.
The change of maximum pain in millimeters on the VAS scale during the 20 minutes following the study drug delivery will be recorded.
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Duration of Labour Analgesia After the Single Dose of Epidural or Intrathecal Opioid
Time Frame: The data below report an average duration of time that is typically less than three hours
|
The time from the study drug dose to the administration of next epidural bolus, up to five hours.
After the study drug dose all parturients wil have epidural catheters in place for subsequent analgesia.
|
The data below report an average duration of time that is typically less than three hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Antti J Vaananen, M.D., Ph.D., Helsinki University Central Hospital (Katiloopiston sairaala)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2016
Primary Completion (Actual)
May 1, 2018
Study Completion (Actual)
May 1, 2018
Study Registration Dates
First Submitted
August 26, 2016
First Submitted That Met QC Criteria
August 30, 2016
First Posted (Estimate)
August 31, 2016
Study Record Updates
Last Update Posted (Actual)
June 10, 2021
Last Update Submitted That Met QC Criteria
May 27, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- §12/19.6.2016/HUS/400/2016
- 2016-000486-23 (EudraCT Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Pain
-
Antalya Bilim UniversityCompletedChildbirth | Normal Labor | Labor Pain and to Reduce PainTurkey (Türkiye)
-
Pınar ErdoğanRecruitingLabor Progress | Labor Pain and AnxietyTurkey (Türkiye)
-
Soovu Labs Inc.Virginia Mason Hospital/Medical CenterNot yet recruiting
-
Bogomolets National Medical UniversityCompleted
-
Martin-Luther-Universität Halle-WittenbergCompleted
-
Maimonides Medical CenterTerminated
-
Aretaieio HospitalRecruitingLabor Pain | Pain, Labor | EpiduralGreece
-
Mashhad University of Medical SciencesTerminatedDecrease Labor Pain
-
Cairo UniversityNot yet recruiting
Clinical Trials on Spinal analgesia for labour pain
-
University of PadovaRecruitingLabor Analgesia | Expectations | Postpartum Depression (PPD)Italy
-
Fondazione IRCCS Policlinico San Matteo di PaviaCompletedLabour Analgesia, Epidural Anaesthesia | Labor, Induced | Duration of LabourItaly
-
Universitaire Ziekenhuizen KU LeuvenNot yet recruitingPregnancy | Epidural Analgesia, ObstetricBelgium
-
University of California, San DiegoPorland Area Indian Health Services - Yakama Service UnitNot yet recruiting
-
Karolinska InstitutetRegion StockholmCompletedLabor Pain | Childbirth Problems | Language | Satisfaction, Consumer | Birth DepressionSweden
-
Mahesh PattabiramanCompletedFailed Back Surgery Syndrome | Chronic Neuropathic Pain | Pain Modulation | Spinal Cord Stimulation (SCS) | Chronic Pain ManagementUnited States
-
Jena University HospitalCompleted
-
University of AlbertaCompletedLow Back Pain | Muscle Weakness | Spine Stiffness | Degeneration of Lumbosacral Intervertebral DiscCanada
-
St. Justine's HospitalNot yet recruitingSatisfaction, Patient | Urinary Retention | Pruritis | Labor Analgesia | Hypotension Drug-Induced | Opioid Analgesic Adverse Reaction | Fentanyl Adverse Reaction | Term Labour | Fetal Bradycardia During Labor | Fentanyl Analgesia | Neuraxial Opioid | Nausea and VomittingCanada
-
Ataturk UniversityRecruiting